Abstract:Breast cancer is the most common type of malignancy among females. Previous studies examining breast cancer tissue have demonstrated the presence of stem cells, and have detected octamer‑binding protein 4 (Oct4) and Nanog transcription factor expression. In the present study, breast cancer stem cells (CSCs) were isolated and enriched from MDA‑MB‑231 breast cancer cell lines, and were defined as MDA‑MB‑231 stem cells using flow cytometry. The expression of Oct4 and Nanog in breast CSCs were detected by quantitative polymerase chain reaction and western blotting. RNA interference (RNAi) was used in order to downregulate the expression of Oct4 and Nanog. Drug resistance and tumor‑initiating capability following in vivo injection of MDA‑MB‑231 stem cells trans-duced with negative RNAi, Oct4 RNAi and Nanog RNAi were compared with that of MDA‑MB‑231 stem cells without siRNA transfection as a control group. In addition the capability of MDA‑MB‑231 breast cancer cells to initiate tumor formation in mice was compared with that of MDA‑MB‑231 stem cells. A paclitaxel inhibition test was also conducted in order to detect resistance of MDA‑MB‑231 breast cancer stem cells to this treatment. The MDA‑MB‑231 stem cells were revealed to exhibit elevated percentages of the cluster of differentiation (CD)44+CD24‑/low subset, high tumorigenicity and resistance to chemotherapy, all of which are characteristic stem cell properties. In addition, the MDA‑MB‑231 stem cells were more tumorigenic in vivo. Furthermore, the breast CSCs also expressed high levels of the Oct4 and Nanog transcription factors. Therefore, downregulation of Oct4 or Nanog expression may reduce chemotherapeutic drug resistance and tumorigenicity in breast CSCs. In conclusion, Oct4 and Nanog expression may be a key factor in the development of resistance to chemotherapy and tumor growth of breast CSCs. This finding indicates that Oct4 or Nanog‑targeted therapy may be a promising means of overcoming resistance to chemotherapy and inhibiting tumor growth in breast cancer treatment.

Downregulation of CXCR7 Inhibits Proliferative Capacity and Stem Cell-Like Properties in Breast Cancer Stem Cells

Silencing Of Cxcr7 Gene Represses Growth And Invasion And Induces Apoptosis In Colorectal Cancer Through Erk And Beta-Arrestin Pathways

Circular RNA profile indicates circular RNA VRK1 is negatively related with breast cancer stem cells.

Quercetin Suppresses Breast Cancer Stem Cells (CD44 + /CD24 − ) by Inhibiting the PI3K/Akt/mTOR-signaling Pathway

Quercetin suppresses breast cancer stem cells (CD44+/CD24−) by inhibiting the PI3K/Akt/mTOR-signaling pathway

Cxcr1 Blockade Selectively Targets Human Breast Cancer Stem Cells in Vitro and in Xenografts

Let-7a Regulates Mammosphere Formation Capacity Through Ras/NF-κB and Ras/MAPK/ERK Pathway in Breast Cancer Stem Cells

Let-7a regulates mammosphere formation capacity through Ras/NF-κB and Ras/MAPK/ERK pathway in breast cancer stem cells.

The Chemokine Receptor CXCR3 Isoform B Drives Breast Cancer Stem Cells

Silencing of Btbd7 Inhibited Epithelial-Mesenchymal Transition and Chemoresistance in Cd133(+) Lung Carcinoma A549 Cells

Reduced Tumorigenicity and Drug Resistance Through the Downregulation of Octamer-Binding Protein 4 and Nanog Transcriptional Factor Expression in Human Breast Stem Cells

Silencing of CXCR4 Sensitizes Triple-Negative Breast Cancer Cells to Cisplatin

CXCR2 is a Novel Cancer Stem-Like Cell Marker for Triple-Negative Breast Cancer.

Resveratrol Inhibits Breast Cancer Stem-Like Cells and Induces Autophagy Via Suppressing Wnt/β-catenin Signaling Pathway.

Targeting CXCR7 Improves the Efficacy of Breast Cancer Patients with Tamoxifen Therapy

Role of microRNAs in the Regulation of Breast Cancer Stem Cells

Downregulation of BUBR1 regulates the proliferation and cell cycle of breast cancer cells and increases the sensitivity of cells to cisplatin

Breast cancer stem-like cells are sensitized to tamoxifen induction of self-renewal inhibition with enforced Let-7c dependent on Wnt blocking

CBX7 Regulates Stem Cell-Like Properties of Gastric Cancer Cells Via P16 and AKT-NF-κB-miR-21 Pathways.

CRB3 Downregulation Confers Breast Cancer Stem Cell Traits Through TAZ/β-catenin

Inhibition of CD147 expression by RNA interference reduces proliferation, invasion and increases chemosensitivity in cancer stem cell-like HT-29 cells